Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029))

Locafaro, G.; Andolfi, G.; Russo, F.; Cesana, L.; Spinelli, A.; Camisa, B.; Ciceri, F.; Lombardo, A.; Bondanza, A.; Roncarolo, M. G.; Gregori, S.

doi:10.1016/j.ymthe.2024.02.012

(Molecular Therapy 25, 2254–2269; October 2017) In the originally published version of this article, there is an error in Figure 8A, where there is a duplication of the mouse pictures at day 5 and day 7. The error occurred during the editing of Figure 8A and does not affect the overall conclusion of the paper. A corrected version of the figure is provided below. The authors apologize for this error and any confusion this may have caused.[Formula presented]

Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) / Locafaro, G.; Andolfi, G.; Russo, F.; Cesana, L.; Spinelli, A.; Camisa, B.; Ciceri, F.; Lombardo, A.; Bondanza, A.; Roncarolo, M. G.; Gregori, S.. - In: MOLECULAR THERAPY. - ISSN 1525-0016. - 32:3(2024), pp. 853-854. [10.1016/j.ymthe.2024.02.012]